Marshall & Sullivan Inc Mannkind Corp Transaction History

Marshall & Sullivan Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 18, 2023	BUY	$3.02 - $5.37 $6,040 - $10,740	2,000 New	2,000 $0
Q2 2022 Jul 06, 2022	BUY	$2.67 - $4.77 $5,340 - $9,540	2,000 New	2,000 $7,000
Q1 2021 May 04, 2021	SELL	$3.14 - $6.14 $18 - $36	-6 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$1.79 - $4.04 $3,569 - $8,055	-1,994 Reduced 99.7%	6 $2 Million
Q3 2020 Nov 02, 2020	BUY	$1.56 - $2.08 $3,120 - $4,160	2,000 New	2,000 $4,000
Q3 2018 Oct 29, 2018	SELL	$1.01 - $2.19 $3,535 - $7,665	-3,500 Closed	0 $0
Q2 2018 Jul 31, 2018	BUY	$1.59 - $2.38 $5,565 - $8,330	3,500 New	3,500 $0

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.75B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Marshall & Sullivan Inc , based on Form 13F filings with the SEC.

Stay updated on Marshall & Sullivan Inc with notifications on news.